SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 4th, 2023 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 4th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 22, 2023, between Omega Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).